Clinical trials in amyotrophic lateral sclerosis: The tenuous past and the promising future

被引:9
|
作者
Choudry, RB [1 ]
Cudkowicz, ME [1 ]
机构
[1] Massachusetts Gen Hosp, Neurol Clin Trials Unit, Dept Neurol, Boston, MA 02114 USA
关键词
amyotrophic lateral sclerosis; clinical trials; drug trials;
D O I
10.1177/0091270005282631
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The post decade of research in amyotrophic lateral sclerosis has contributed to a greater understanding of the disease-process, the development of relevant animal models, and the identification of several therapeutic approaches that may delay disease progression. Completed and ongoing clinical trials and the process of selecting drugs for clinical trials are presented.
引用
收藏
页码:1334 / 1344
页数:11
相关论文
共 50 条
  • [41] Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis
    Cunha-Oliveira, Teresa
    Montezinho, Liliana
    Simoes, Rui F.
    Carvalho, Marcelo
    Ferreiro, Elisabete
    Silva, Filomena S. G.
    CELLS, 2024, 13 (03)
  • [42] Rethinking phase 2 trials in amyotrophic lateral sclerosis
    Benatar, Michael
    Mcdermott, Christopher
    Turner, Martin R.
    van Eijk, Ruben P. A.
    BRAIN, 2025, : 1106 - 1111
  • [43] Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials
    Gordon, Paul H.
    AGING AND DISEASE, 2013, 4 (05): : 295 - 310
  • [44] Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers
    Gagliardi, Delia
    Bresolin, Nereo
    Comi, Giacomo Pietro
    Corti, Stefania
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2021, 78 (02) : 561 - 572
  • [45] Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers
    Delia Gagliardi
    Nereo Bresolin
    Giacomo Pietro Comi
    Stefania Corti
    Cellular and Molecular Life Sciences, 2021, 78 : 561 - 572
  • [46] Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?
    Atassi, Nazem
    Beghi, Ettore
    Blanquer, Miguel
    Boulis, Nicholas M.
    Cantello, Roberto
    Caponnetto, Claudia
    Chio, Adriano
    Dunnett, Stephen B.
    Feldman, Eva L.
    Vescovi, Angelo
    Mazzini, Letizia
    CYTOTHERAPY, 2016, 18 (12) : 1471 - 1475
  • [47] Clinical and research applications of neuromuscular ultrasound in amyotrophic lateral sclerosis
    Barnes, Stephanie L.
    Simon, Neil G.
    DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2019, 9 : 89 - 102
  • [48] Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis
    Stephen A. Goutman
    Kevin S. Chen
    Eva L. Feldman
    Neurotherapeutics, 2015, 12 : 428 - 448
  • [49] Clinical neurorestorative progress in amyotrophic lateral sclerosis
    Chen, Lin
    Huang, Hongyun
    Xi, Haitao
    Mao, Gengsheng
    JOURNAL OF NEURORESTORATOLOGY, 2015, 3 : 109 - 114
  • [50] Clinical and genetic heterogeneity of amyotrophic lateral sclerosis
    Sabatelli, M.
    Conte, A.
    Zollino, M.
    CLINICAL GENETICS, 2013, 83 (05) : 408 - 416